Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized Study to Describe the Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

Next Previous
Trial Profile

A Randomized Study to Describe the Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 09 Oct 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary) ; DTaP poliovirus vaccine; Hepatitis B vaccine; Measles mumps and rubella virus vaccine; Pneumococcal vaccine conjugate; Rotavirus vaccine; Varicella vaccines
  • Indications Meningococcal infections
  • Focus Adverse reactions; Registrational
  • Acronyms MET41
  • Sponsors Sanofi Pasteur

Most Recent Events

  • 31 Mar 2023 Status changed from active, no longer recruiting to completed.
  • 03 Jan 2023 Planned End Date changed from 1 Mar 2023 to 1 Apr 2024.
  • 03 Jan 2023 Planned primary completion date changed from 1 Mar 2023 to 1 Apr 2024.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top